Core Points - Pingtan Development and Haixia Innovation have completed their suspension review and will resume trading on November 21, 2025 [1][2] - Eddy Precision and Hangcai Co. plan to repurchase shares [3] - Wenfeng Co.'s deputy general manager has been placed under investigation [4] - Kesi Co. has undergone a change in its actual controller [6][7] - Major events include the completion of restructuring investments by *ST Lian Shi and acquisitions by Jun Ting Hotel and Lek Electric [8][9] Group 1: Resumption of Trading - Pingtan Development's stock will resume trading on November 21, 2025, after confirming no significant changes in its operations or undisclosed major matters [1] - Haixia Innovation's stock will also resume trading on November 21, 2025, with similar confirmations regarding its operational status [2] Group 2: Share Repurchase Plans - Eddy Precision plans to repurchase shares with a total amount between 100 million and 200 million yuan, at a price not exceeding 27 yuan per share [3] - Hangcai Co. intends to repurchase shares using excess funds, with a total amount between 50 million and 100 million yuan, at a price not exceeding 80 yuan per share [3] Group 3: Investigations and Changes in Management - Wenfeng Co.'s deputy general manager, Qin Guofen, is under investigation, but the company states this will not significantly impact its operations [4] - Kesi Co. has changed its actual controller from Zhou Jiuqing and Zhou Xuming to Zhou Xuming alone following the death of Zhou Jiuqing [6][7] Group 4: Major Events - *ST Lian Shi has received a total of 1.238 billion yuan in restructuring investments from all investors [8] - Jun Ting Hotel has agreed to acquire the remaining 21% stake in Junlan Management for 79.8 million yuan, making it a wholly-owned subsidiary [9] - Lek Electric plans to transfer 90% of its subsidiary's equity to Chuangyuan Resources, with a target valuation of 235 million yuan [9]

Major Announcements - EVE Energy signed a procurement framework agreement with Smoore International for the continuous supply of battery cells and other products as raw materials, with actual amounts to be determined by future orders [3] - ST Huami's stock is under "double risk" warning due to an audit report expressing inability to provide an opinion for the 2024 financial report, with a recovery of 1.567 billion yuan in occupied funds [4] - Wuzhou Transportation received a regulatory warning for accounting irregularities and failure to fulfill integrity checks for executives, leading to inaccurate financial disclosures [5] - Wenfeng Co. announced that its vice president is under investigation, but this will not significantly impact the company's operations [6] - Fosun Pharma's subsidiary has had its drug included in the breakthrough therapy designation program for gastric cancer treatment, marking a significant development in its product pipeline [7][8] - Shandong Steel's subsidiary is applying for bankruptcy liquidation, which is expected to increase the parent company's net profit by 15.88 million yuan [9] - Zhouming Technology established a new subsidiary, Shenzhen Zhixian Robotics Co., with a registered capital of 50 million yuan [10] Share Buybacks and Holdings - Spring Airlines conducted its first share buyback, acquiring 35,800 shares for a total of 1.9997 million yuan [11] - Donghua Software's controlling shareholder reduced his stake by 1%, selling 10.9832 million shares [12] - Changshu Bank's executives plan to increase their holdings by at least 550,000 shares over the next six months [13] Major Contracts - Nanfeng Co. won contracts worth 45.7 million yuan and 47.17 million yuan for HVAC systems, with delivery scheduled for 2027 [14] - Huakang Clean announced a pre-bid win for a purification system project at Keqiao Future Medical Center, with a bid price of 176 million yuan [15][16] - Qinglong Pipe Industry secured a contract worth 294 million yuan for a pipe procurement project, expected to impact its performance from 2026 to 2030 [17] - China Nuclear Engineering signed new contracts totaling 123.84 billion yuan as of October, with cumulative revenue of 81.334 billion yuan [18]

Core Insights - On November 20, several companies disclosed their share repurchase and reduction plans, indicating varying levels of confidence in their stock performance [1] Group 1: Share Repurchase Plans - Eddie Precision plans to repurchase A-shares worth between 100 million to 200 million yuan [2] - Aviation Materials plans to repurchase shares worth between 50 million to 100 million yuan [2] - Changshu Bank's executives plan to increase their holdings by no less than 550,000 shares [2] Group 2: Share Reduction Plans - New Hongze's major shareholder reduced their holdings during a period of abnormal stock fluctuations [2] - General Electric's Singapore company plans to reduce its holdings by no more than 3% in China Xidian [2] - Senior management of Lifespring Pharmaceutical plans to reduce their holdings by no more than 0.0044% [2] - Shareholder Zhoushan Ruihao of Wan Feng plans to reduce holdings by no more than 1.75% [2] - Shareholders of Dongxin plan to collectively reduce holdings by no more than 0.71% [2] - Haigang Group, a shareholder of Hainan Mining, plans to reduce holdings by no more than 0.75% [2] - Actual controller Zhang Guifeng of Fulongma reduced 3.7812 million shares from November 19 to November 20 [2] - Shareholder Dongguan Kechuang Investment Group of Shengyi Electronics plans to reduce holdings by no more than 1% [2] - Shareholder Qinyi Partnership of Yayi Technology plans to reduce holdings by no more than 0.25% [2] - Controlling shareholder Yuansi Industrial of New City plans to reduce holdings by no more than 3% [2] - Controlling shareholder of Kaishan plans to reduce holdings by no more than 1% [2] - The largest shareholder of Tuo Jing Technology, the National Fund, plans to reduce holdings by no more than 3% [2] - Controlling shareholder Li Zheng of Wajinjiao plans to reduce holdings by no more than 3% [2] - Shareholder Shanxi Huaxin Hai of Baose plans to reduce holdings by no more than 1% [2] - Shareholders of Huaya Intelligent plan to collectively reduce holdings by 399.21 million shares, accounting for 2.98% of total share capital [2] - Directors and executives of Changxin Bochuang plan to collectively reduce holdings by no more than 0.05% [2] - Shareholders of Longxun plan to collectively reduce holdings by no more than 2.63% [2] - Some directors and executives of Fulede plan to collectively reduce holdings by no more than 0.0104% [2]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ MACD金叉信号形成，这些股涨势不错！ | | | 11.20上市公司盘后增持情况 | | --- | --- | --- | | 1 | 文迪精密 | 拟1亿元-2亿元回购公司A股股份 | | 2 | 航材股份 | 拟5000万元1亿元回购公司股份 | | 3 | 常熟银行 | 部分高管计划增持本行A股股份不少于55万股 | | | | 11.20上市公司盘后减持情况 | | 1 | 新宏泽 | 股票异常波动期间 控股股东存在减持公司股票的情形 | | 2 | 中国西电 | 通用电气新加坡公司计划减持不超3%公司股份 | | 3 | 力生制药 | 高级管理人员郭晓燕计划减持不超0.0044%公司股份 | | 4 | 万丰股份 | 股东舟山瑞好拟减持不超1.75%股份 | | ਦ | 东心股份 | 股东拟合计减持不超0.71%公司股份 | | 6 | 一百时时 | 股东海钢集团拟减持不超0.75%股份 | | 7 | 福龙马 | 实际控制人张桂丰11月19日至11月20日减持378.12万股 | | 8 | 生益电子 | 股东东莞科创投 ...

证券日报网讯 11月20日晚间，常熟银行发布公告称，基于对本行内在价值、未来战略规划及长远发展 前景的坚定信心，坚信本行股票长期投资价值，本行行长陆鼎昌先生，副行长张康德先生、干晴女士、 程鹏飞先生、倪建峰先生，董事会秘书唐志锋先生（以下简称"增持主体"）计划自公告披露之日起6个 月内，通过上海证券交易所交易系统集中竞价交易方式合计增持本行A股股份不少于55万股。陆鼎昌先 生的行长任职资格，张康德先生、倪建峰先生的副行长任职资格尚需取得国家金融监督管理总局苏州监 管分局核准。本次增持主体增持所需的资金来源为自有资金，不存在因所需资金不到位而导致后续增持 无法实施的风险。 （文章来源：证券日报） ...

Group 1 - Moer Thread announced an issuance price of 114.28 CNY per share, with a total of 70 million shares to be publicly issued, aiming to raise 8 billion CNY, netting approximately 7.576 billion CNY after expenses [1] - EVE Energy signed a procurement framework agreement with Simo International for battery cells from 2026 to 2028, with the agreement effective until December 31, 2028, but does not specify a concrete amount [1] - Tuojing Technology's major shareholder, the National Integrated Circuit Industry Investment Fund, plans to reduce its stake by up to 3% through block trading from December 12, 2025, to March 11, 2026 [1] Group 2 - Shengyi Electronics announced that its shareholder, Dongguan Science and Technology Innovation Investment Group, plans to reduce its stake by up to 1% from December 12, 2025, to March 11, 2026, due to funding needs [2] - Deep Technology reported that it is a leading domestic high-end storage chip packaging and testing company, currently operating at full capacity in Shenzhen and Hefei, and is expanding based on customer demand [2] - Wengfeng Co. announced that its deputy general manager, Qin Guofen, is under investigation, but this matter is personal and will not significantly impact the company's operations [2] Group 3 - Fosun Pharma's subsidiary, Shanghai Fuhong Hanlin Biotechnology, has had its drug, Surulitinib, included in the breakthrough therapy designation for gastric cancer, with no other PD-1 monoclonal antibody approved for this indication globally [3] - Daye Co. is responding to the EU's anti-dumping investigation on Chinese lawnmowers, adjusting its overseas production structure and integrating resources to mitigate impacts [4]

| 增持主体名称 | 陆鼎昌、张康德、干晴、程鹏飞、倪建峰、唐志锋 | | --- | --- | | 拟增持股份目的 | 基于对本行内在价值、未来战略规划及长远发展前景 | | | 坚定信心,坚信本行股票长期投资价值。 | | 拟增持股份种类 | 本行 A 股股份 | | 拟增持股份方式 | 通过上海证券交易所系统以集中竞价方式 | | 拟增持股份数量 | | | | 陆鼎昌拟增持不低于 20万股; 张康德拟增持不低于 5万股; | | | 干晴拟增持不低于 5万股; | | | 程鹏飞拟增持不低于 10万股; | | | 倪建峰拟增持不低于 10万股; | | | 唐志锋拟增持不低于5万股。 | | 拟增持股份价格 | 本次增持股份不设价格区间 | | 本次增持计划实施期间 | 自 2025 年 11 月 21 日起 6 个月内 | | 拟增持股份资金来源 | 自有资金 | | 拟增持主体承诺 | 增持主体在增持后的6个月内将不减持本次增持的 | | | 份。 | （常熟银行） 11月20日，常熟银行（601128）发布公告称，基于对该行内在价值、未来战略规划及长远发展前景的坚定信心，坚信该行股票长期投资 ...

常熟农商行指出，本次增持主体增持所需的资金来源为自有资金，不存在因所需资金不到位而导致后续 增持无法实施的风险。陆鼎昌的行长任职资格，张康德、倪建峰的副行长任职资格尚需取得国家金融监 督管理总局苏州监管分局核准。 北京商报讯(记者宋亦桐)11月20日，常熟农商行发布公告指出，基于对该行内在价值、未来战略规划及 长远发展前景的坚定信心，坚信该行股票长期投资价值，该行行长陆鼎昌，副行长张康德、干晴、程鹏 飞、倪建峰，董事会秘书唐志锋(以下简称"增持主体")计划自公告披露之日起6个月内，通过上海证券 交易所交易系统集中竞价交易方式合计增持该行A股股份不少于55万股。 ...

Group 1 - EVE Energy signed a procurement framework agreement with its affiliate, Smoore International, for continuous procurement of battery cells starting from January 1, 2026 [1] - Zhaoyi Information plans to issue H-shares and list on the Hong Kong Stock Exchange [1] - Fuke Environmental announced a change in its stock abbreviation to "Fuke Technology" effective November 26 [1] Group 2 - Dajia Weikang's shareholder and director terminated a share reduction plan ahead of schedule, having reduced 1% of total shares [2] - Aohong Electronics received approval from the China Securities Regulatory Commission for the issuance of convertible bonds [2] - Yingfeng Environment's controlling shareholder plans to issue exchangeable bonds not exceeding 1 billion yuan [2] Group 3 - Longshen Rongfa's subsidiary obtained a renewed drug production license covering various pharmaceutical products [4] - Xinhua News' subsidiary invested 15 million yuan in a fund with a total commitment of 221 million yuan [5] - Guang'an Aizhong appointed two new deputy general managers [6] Group 4 - Fosun Pharma's subsidiary's drug for gastric cancer treatment was included in the breakthrough therapy program by the National Medical Products Administration [7] - Nanjiao Foods reported a significant decline in October net profit due to rising raw material costs [8] - Nanfeng Co. won two nuclear power project bids totaling 928.7 million yuan [10] Group 5 - Puluo Pharmaceutical received a drug registration certificate for its Cefdinir capsules [11] - Liming Co.'s subsidiary received environmental approval for a new pesticide raw material project [12] - Longhua New Materials' expansion project for polyether polyols has commenced trial production [13] Group 6 - Pumen Technology's products received IVDR CE certification from TÜV Rheinland [15] - China Chemical reported new contracts worth 312.67 billion yuan from January to October [18] - China Nuclear Construction achieved new contracts totaling 123.84 billion yuan as of October [19] Group 7 - Changshu Bank's executives plan to purchase at least 550,000 shares of the bank [20] - Shandong Steel's subsidiary is applying for bankruptcy liquidation to focus on core business [21] - Huakang Clean is expected to win a bid for a purification system project worth 176 million yuan [23] Group 8 - Huawu Co. plans to internally transfer subsidiary equity [24] - Tianen Kang's subsidiary received clinical trial acceptance for a new drug [26] - Tianyi Medical's subsidiary obtained a medical device registration certificate for a blood dialysis product [27] Group 9 - Xuelang Environment is facing a pre-restructuring application from creditors [27] - Chitianhua's subsidiary resumed production after passing safety inspections [28] - Huaping Co.'s director plans to reduce 0.03% of company shares [30] Group 10 - Xizhuang Co. plans to establish a wholly-owned subsidiary in Singapore [31] - Ruisheng Intelligent's subsidiary won a 60.23 million yuan ICT project bid [32] - Junyi Digital plans to invest 120 million yuan in Guanghong Precision [33] Group 11 - Fuguang Co.'s controlling shareholder plans to increase holdings between 80 million to 150 million yuan [34] - Ganyue Express reported a 13.68% increase in logistics revenue in October [39] - Jiangsu Sop terminated its 2025 private placement plan [41] Group 12 - Langke Intelligent's shareholders plan to reduce a total of 1.68% of company shares [42] - Yuantong Express reported an 8.97% increase in express product revenue in October [45] - Jinbei Automotive plans to invest 158 million yuan to acquire 52% of Zhongtuo Technology [46]

Group 1 - Company Yiwei Lithium Energy signed a procurement framework agreement with Simor International on November 20, 2025, for the continuous supply of battery cells and other products as raw materials, with actual amounts to be determined by future orders [1] - ST Huamei's stock is under "double risk" warning due to an inability to express an opinion in its 2024 financial report, with a recovery of 1.567 billion yuan in occupied funds as of August 15, 2025, and the stock remains under risk warning with a 5% trading limit [2] - Wuzhou Transportation received a regulatory warning from the Shanghai Stock Exchange for non-compliance in accounting practices and failure to fulfill integrity checks for executives, requiring a rectification report [3] Group 2 - Wenkang Co.'s deputy general manager Qin Guofen is under investigation, but the company states this will not significantly impact its operations [4] - Fosun Pharma's subsidiary Shanghai Fuhong Hanlin's drug, SLR-121, has been included in the breakthrough therapy designation for gastric cancer treatment, marking a significant milestone as no PD-1 monoclonal antibody has been approved for this indication globally [5] - Shandong Steel's subsidiary plans to apply for bankruptcy liquidation, which is expected to increase the parent company's net profit by 15.88 million yuan, allowing the company to focus on its core business [6] Group 3 - Zhuhai Ming Technology established a new subsidiary, Shenzhen Zhixian Robotics Co., with a registered capital of 50 million yuan, in which Zhuhai Ming holds a 50% stake [7] - Spring Airlines conducted its first share buyback, repurchasing 35,800 shares for a total of 1.9997 million yuan, representing 0.0037% of its total share capital [9] - Donghua Software's controlling shareholder reduced his stake by 1%, bringing his direct holding down to 10.90%, in line with a previously disclosed plan [11] Group 4 - Changshu Bank's executives plan to increase their holdings by at least 550,000 shares over the next six months, with specific minimum amounts for each executive [12] - Nanfeng Co. won contracts worth 45.7 million yuan and 47.17 million yuan for HVAC systems, with delivery dates set for July and August 2027, respectively [14] - Huakang Clean's bid for the Keqiao Future Medical Center purification system project was successful, with a bid amount of 176 million yuan [15] - Qinglong Pipe Industry secured a contract worth 294 million yuan for a pipe procurement project, expected to impact its performance from 2026 to 2030 [16] - China Nuclear Engineering signed new contracts totaling 123.84 billion yuan and achieved revenue of 81.334 billion yuan as of October 2025 [17]